On October 14, Astera Labs, Inc. fell 3.05% in Pre-Market Trading, trading at $315.6 per share, with turnover of $5.9628 million.
The move followed continued pressure after Northland Securities downgraded the stock to market perform from outperform, while profit-taking sentiment persisted ahead of the company’s November 3 third-quarter results release.
Recent coverage showed the downgrade had already weighed on the shares across overnight, pre-market, and regular trading sessions earlier this week. Even so, broader analyst consensus remained comparatively constructive, with an average rating of overweight or buy-equivalent and a mean target price of $416.78, while market expectations for the next reported quarter imply EPS of $0.83. The latest decline suggests the downgrade’s sentiment impact is still outweighing unchanged broader consensus expectations in the near term.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments